SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-026105
Filing Date
2023-02-27
Accepted
2023-02-27 17:16:30
Documents
2
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm237906-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm237906-1_3seq1.xml 3 2234
2 EXHIBIT 24.1 tm237906d1_ex24-1.htm EX-24.1 8996
  Complete submission text file 0001104659-23-026105.txt   12604
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
Onyia Jude (Reporting) CIK: 0001894425 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37625 | Film No.: 23676605